As early as 8 weeks after induction of diabetes, approximately 80% of mice treated with MC1–MC5 antagonists display appearance of venous loop with marked leakage, due to an increased vascular permeability, and vascular tortuosity. This evidence concerns the gene ATP7A and diabetes mellitus.